2024-03-29T01:52:18Z
https://nagoya.repo.nii.ac.jp/oai
oai:nagoya.repo.nii.ac.jp:02001167
2023-11-16T02:04:49Z
499:508:509:1624513305190
The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis
Zhang, Jiudan
Chen, Ye
Wang, Jian
Xia, Hong
Zheng, Yang
liraglutide
insulin allergy
multiple sclerosis
steroid-induced diabetes mellitus
Glucocorticoid use may trigger secondary diabetes or exacerbate hyperglycemia in patients with diabetes mellitus (DM). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of patients with type 2 diabetes. Few reports mention liraglutide as a treatment for steroid-induced DM (SIDM). Here, we report a patient with SIDM and multiple sclerosis, for whom switching to liraglutide combined with metformin therapy improved glucose levels and ameliorated the symptoms of insulin allergy. Liraglutide may be useful for treating SIDM with insulin allergy.
departmental bulletin paper
Nagoya University Graduate School of Medicine, School of Medicine
2021-05
application/pdf
Nagoya Journal of Medical Science
2
83
343
351
0027-7622
2186-3326
https://nagoya.repo.nii.ac.jp/record/2001167/files/13_Zhang.pdf
eng
https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/832.html
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International